DW Healthcare Partners Invests in Parnell
News provided by
Share this article
Share this article
PARK CITY, Utah, Feb. 1, 2021 /PRNewswire/ DW Healthcare Partners ( DWHP ) a healthcare-focused private equity firm, announced the completion of its investment in Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF) ( Parnell or the Company ). Founded over 50 years ago in Australia, Parnell is a fully integrated manufacturer and developer of animal health pharmaceuticals focused on the US market. Parnell has an attractive position with an FDA approved manufacturing facility dedicated to animal health drugs with a particular focus on sterile injectables, said Eric Moore, Principal at DWHP. Alan and Brad have done a great job building a quality and compliance culture at the Company and over the last three years have dramatically transformed the organization. We look forward to helping them accelerate growth in the coming years.